Rallybio Corporation

NASDAQ:RLYB

Biotechnology

Healthcare
$15.52 +0.03%

+$0.01 today

Market cap
$83.56M
Beta
-0.88
P/E (TTM)
-11.6
EPS (TTM)
-$1.37
52W Low $2.40High $17.57

Volume 0.04M

Average 0.25M

Balance Sheet

Inspect the capital base behind the business.

Assets

$62.26M

FY 2025 · Annual

-8.6% YoY

Liabilities

$4.30M

FY 2025 · Annual

-33.3% YoY

Equity

$57.96M

FY 2025 · Annual

-6.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents175.33M56.96M24.49M13.9M31.37M
Short-term Investments0112.04M85.44M51.61M23.36M
Net Receivables00000
Inventory00000
Other Current Assets395K1.05M2.05M995K2.52M
Total Current Assets180.87M179.5M114.79M67.84M61.25M
Property, Plant & Equipment (Net)511K909K592K267K198K
Goodwill00000
Intangible Assets00000
Long-term Investments805K30K239K00
Tax Assets00000
Other Non-current Assets0000810K
Total Non-current Assets1.32M939K831K267K1.01M
Total Assets182.19M180.44M115.62M68.11M62.26M
Account Payables603K1.11M976K278K126K
Short-term Debt00000
Tax Payables00000
Deferred Revenue000848K212K
Other Current Liabilities2.99M4.7M3.17M3.1M1.46M
Total Current Liabilities6.55M10.74M9.26M6.24M4.22M
Long-term Debt0374K000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)000212K0
Other Non-current Liabilities32K(374K)000
Total Non-current Liabilities32K374K173K212K82K
Total Liabilities6.58M11.12M9.44M6.45M4.31M
Common Stock3K4K4K4K4K
Retained Earnings(94.03M)(160.68M)(235.25M)(293.02M)(302M)
Accumulated OCI0(214K)15K68K18K
Other Stockholders Equity00000
Minority Interest00000
Total Equity175.6M169.32M106.18M61.65M57.96M
Total Debt0555K392K154K176K
Net Debt(175.33M)(56.4M)(24.1M)(13.75M)(31.2M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$41.3M
Short-term Investments$5.5M
Other Current$6.7M
Total Current Assets$53.5M
PP&E (Net)$172.0K
Other Non-current$810.0K
Total Non-current Assets$982.0K
Total Assets$54.5M

Analysis

Selected assets total $54.5M for Latest. The largest visible component is Cash & Equivalents at $41.3M, about 75.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
425425 filingNov 12, 2026
8-KCurrent reportNov 10, 2026
425425 filingNov 10, 2026
8-KCurrent reportNov 6, 2026

How much cash does RLYB have?

Rallybio Corporation (RLYB) reported $31.37M in cash and equivalents in fiscal 2025.

How much debt does RLYB carry?

Rallybio Corporation (RLYB) reported $176,000.00 of total debt, with net debt of -$31.20M.